EDITAS Medicine

Beam Therapeutics

The company develops precision genetic medicines using base editing technology to treat patients with serious genetic diseases such as sickle cell disease.

Alia Therapeutics

The company develops gene editing medicines for patients with genetic diseases.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Metagenomi

Metagenomi develops genome editing tools and genetic medicines for patients with genetic mutations.

Tessera

The company develops genome engineering platforms to write therapeutic DNA sequences into cells for clinicians and researchers treating genetic diseases.

Immitra Bio

This company develops an in-vivo gene editing platform to provide off-the-shelf curative treatments for patients with rare genetic diseases.

Arbor Biotechnologies

This company develops programmable gene-editing tools and genetic medicines to treat patients with liver and central nervous system diseases.

LogicBio

This company develops gene editing and delivery platforms to provide one-time treatments for patients with serious, early-onset rare genetic diseases.